OrSense NBM 200MP Continuous Noninvasive Hemoglobin Monitor Wins FDA Clearance
OrSense (Petach Tikva, Israel) received FDA clearance to bring the company’s NBM 200MP hemoglobin monitor to the U.S., a system that the company hopes will help detect and prevent anemia in hospitalized patients. The device continuously measure...
Source: Medgadget - Category: Technology Consultants Authors: Editors Tags: Anesthesiology Cardiology Critical Care Emergency Medicine Source Type: blogs
More News: Anemia | Anesthesia | Anesthesiology | Cardiology | Emergency Medicine | Heart | Middle East Health | Perfusion | Technology Consultants